{"name":"Kazia Therapeutics Limited","slug":"kazia-therapeutics-limited","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPZGhlaXJlUjZaakRneElXblcwVnhFSDQ0eVhwMTd2YlpDZEJMNkdNdHVseV9lR1h4cnI5cDZBTW9UcTB6NEJ2VkVwM2daWVdXQXVrUDhkamdiNW1zbkd2RjE5NGhUNVltTDVVTjY1SFdxZ0xVU2JLTGhYVDV3MjlzMjc0ZjV2SDlSUHZjUnlQVnFqSXlrRDB1c0dYSklIUWo4Mmc?oc=5","date":"2025-10-29","type":"deal","source":"BioWorld News","summary":"Angelini signs $550M deal for Sovargen’s ASO drug in epilepsy - BioWorld News","headline":"Angelini signs $550M deal for Sovargen’s ASO drug in epilepsy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxOU2FzdjJrS3dJQXlndVFrcVpuVEJjc3VVMEszVVRlQ2dHWmJrbXNOSXNBa3p2VTNNYThXQlV5ekZZaVM1T1o1dWljQnFwRGNRRnRtc0Q2bF9qRmlmS3l1U0J0S016aG1rOFB1SHJnWlJqUGVwemxRT2xkOEgtZklkMzB3NjJ2NHFPVm1RN1NJc2s0U0N0dG9oWTh6NDNrNGQ2TFlHbU5mXzRvc3FWUTNCV1cxYU1Qb1hzMUxfQUwzSWs2Q3pBRUhUMjdQR19pNmx0TDBIbFJtX0kwSmFsLWtnQU1uN2NjNUdYMGxLb0FuMFdfQQ?oc=5","date":"2025-10-28","type":"regulatory","source":"BioPharma APAC","summary":"Kazia Therapeutics Seeks FDA Guidance on Paxalisib Survival Data in Glioblastoma Under Project FrontRunner Framework - BioPharma APAC","headline":"Kazia Therapeutics Seeks FDA Guidance on Paxalisib Survival Data in Glioblastoma Under Project FrontRunner Framework","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxOM0Nsc1pfak51TEh5Wlk1MzNBMm93UnQ4aEhaMHdiejZLNFlic0RNQmhBS2p2N0hMY2dRX0kxcGw3cVIxZUhoWHRPamF2WmQwZzhJcVlvcWNHbzR0aDBwNVhHUEdvOGgzU2g1dlpnM0VaRExyeGl4SGRoM09MVjJPaGFhdHR6VWtvaUZUNmF6WnlCWnJNdXY5ZEY3WDJORHdheldrNXJQRjBON2dVdVlGc3RMbWJFVVZzMU5BRm5td2tfZnpoam9QSHlDemlOSks2dmww?oc=5","date":"2025-10-09","type":"deal","source":"BioPharma APAC","summary":"Kazia Therapeutics Partners with QIMR Berghofer to Develop First-in-Class PD-L1 Degrader NDL2 - BioPharma APAC","headline":"Kazia Therapeutics Partners with QIMR Berghofer to Develop First-in-Class PD-L1 Degrader NDL2","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygJBVV95cUxQY2NqMERXc0JnV3ZsTldjSExFWTVWVG9pTS15elp1X2dwak1UNGFCVHlkRlhNQV9ka3ZVbkN4Yjc4dmJBT19BUE5OcE9JdlpIZk4ydEhjekc1YVlXMmVxcjQ2VUtCbE5LSDRFM3NPR0NxakVlNUZ3VDB0N0NCaWpLRjJ1cVBPRUk3LWtWVXlQandvTFRkN2ZreEk2S25Kb2lDc08yd0ViS2VCWkV3T0dXTmpVXzVfZUJvMUZwdi1rWXBBeXhVOHRwOEtqM053OGtYb0RFMjBrSUF6cU1qcjFadDhsVXlDc3Y3QWVIdXpNcWtyWmNXZmdxMTdmeTZCR0JRNXhXcGprSFpxbFJLdTE3U2F3OHdtWEF6TWpfbmd0SkhuaEwtUFdHVXUtbGg3SkFkM0tVUmJxWjUzNXF2QkxGRVpUYkk4VWJxdEE?oc=5","date":"2025-06-11","type":"trial","source":"PR Newswire","summary":"Kazia Therapeutics Announces Transformative Preclinical Data Demonstrating Paxalisib's Potential to Overcome Immunotherapy Resistance in Triple-Negative Breast Cancer (TNBC) - PR Newswire","headline":"Kazia Therapeutics Announces Transformative Preclinical Data Demonstrating Paxalisib's Potential to Overcome Immunothera","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9QZEVvajRtTUpweFF4V181ZkZRR2hWZS1zclREb0Jjb0lNRWx1eTZZMm9YSXhXN1h0YnowRnFibkZfWHAzYXhUay01S1had0lFWGtn?oc=5","date":"2025-04-25","type":"pipeline","source":"Stock Titan","summary":"KZIA Stock Price, News & Analysis - Stock Titan","headline":"KZIA Stock Price, News & Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAJBVV95cUxQQk1sTk4xVWFYbmZFbEYyYnBHM0VBdXhxdEdSdHFhTmlpdDZUanZCSy1WNGkwMmhRSktrdF9DNFpsRU1rRE5jSm5uaXlvMHdndVVfZWw4LUFoMXdFZU1XVEsyVGZja1djeEtfNW95Z3ZpZWx5b3ViWmNDMGZiUlhINmlxaHVJNXdBYy1ualNFVkpFSjBfM1FVa1V3YW81bGR0SlJleE1Vd1NYdW5FTnFXQUdHOXBwVkgxX3YtaEctaXJWQl9DNGlzNFpESFg3TExZaTE5bUZxOHBCMmlJcnl1bG5ubHZFOUJtU2dydW5xdEVZWlpnbDBjZm1xV0J5SmhsWTlVYlBBT19nS0hNLV9BNXRDRXNTWkhNMlBRMmNKUk5fbjVjZDVLR1NacTFRYmt1?oc=5","date":"2025-01-30","type":"trial","source":"PR Newswire","summary":"Kazia Therapeutics announces the launch of a groundbreaking trial with paxalisib in combination with immunotherapy in women with advanced breast cancer - PR Newswire","headline":"Kazia Therapeutics announces the launch of a groundbreaking trial with paxalisib in combination with immunotherapy in wo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxNWnBibS0taVZDTDd2N3NwR2MzejRGVlV0TXg2UnNEdk1ERmZNMzZEeFI0b0xsbkxueHhfZlNrZTFKZ0xFanM3b0QtSzRnUFMwMW56alY2N3lfY0xKSEkyaldCMkVraGtMQVNsNmNvckdzRjQ4Ym96MHVwWUlmMEhwS1oweEZQVXQ4V002WVc3YTBsc1ZqSnRvcWRscUlXZFdn?oc=5","date":"2024-07-11","type":"trial","source":"Clinical Trials Arena","summary":"Kazia Therapeutics stocks soar following Phase II/III win - Clinical Trials Arena","headline":"Kazia Therapeutics stocks soar following Phase II/III win","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUEFVX3lxTE0walNUQTZqbVQ5T3F5RWxjN2o2ZTkyaENpTENmZzYySnRtdGx2WGZTUXRJUVdiaWxRODNTcldpWEduRDVQSTN3TWQ3dVZ1NVI1?oc=5","date":"2024-03-29","type":"pipeline","source":"CNN","summary":"symbol__ Stock Quote Price and Forecast - CNN","headline":"symbol__ Stock Quote Price and Forecast","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE9vSW9wT1IxYU1VMXVNMkh5dUU4WDNfN1hwNnA3cGRTMllDWTAzNlRYeFVzVUhSNHl0dEZ3Njl4VE04LS1TdVpXN3RyYVdWT1ZvZjY5azExR1I1eWxZRFhIT2FSbkFVRzJuYVI5MUc4cjJXZ1YxaDRCYkNzUFc?oc=5","date":"2022-03-07","type":"pipeline","source":"Proactive financial news","summary":"Kazia Therapeutics Ltd Share Price - KZIA, RNS News, Articles, Quotes, & Charts - Proactive financial news","headline":"Kazia Therapeutics Ltd Share Price - KZIA, RNS News, Articles, Quotes, & Charts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxNVWhFS05Bb1Jjd1g5eEtGVHVQSm5sU1MxMVIxU1JhSEpVX0JBMWNUWjVGNjlKTTlUdFdIVzMzbjdnYkp0UFR4QXdaeUlDT2s1ZkdMNGNNYVZDakQxVzh6YWhwX3JoWlNOcFA4eWlqdzBqdUQ4a3VsRVBwTHNYQ3B3R3A1OEhBczZFMWpUM3JUVkZ0WGpSMDE2WmlETGlzX1NOUFdyVzFqbFlwc3ZXZ21PcE5VOUhsbXFZXzU0d3FiVEtRQnREYk9nTGFuUkhsWWJXY3dvOFln?oc=5","date":"2021-04-05","type":"pipeline","source":"BioSpectrum Asia","summary":"Australian oncology drug Paxalisib receives rights to develop and commercialize in China - BioSpectrum Asia","headline":"Australian oncology drug Paxalisib receives rights to develop and commercialize in China","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8AFBVV95cUxOVTdPdXBjUnNiUktmS1pGcDNMUnB1dk9aUlRXRmU1bGJOUDVoa1JvWXhjUkJSWFRPcmg2S1lUM2RDb08yX2hDTlZFMXBSc0lMemhNT0JFUlpVb0dQeVFDaVBWWjVaaTRVaklEampjZ3BFVWd3b0VYbmNiQlpONGo4YTNUTlRZUEl1N3AzTnBVaGRrTmd0ekF5MFVOZ1lDNi0yOWRKQm5MazQzSkpMTFpRNzkyQzJPQ3hBV013RE9id2tqTFFkcV9HYXcyS2MtNXN4NF9Ra3VvbTdRWmYySlJjMzlKTW0weEF2cVRXbFV2Mlo?oc=5","date":"2021-03-29","type":"deal","source":"PR Newswire","summary":"Kazia Licenses Rights to Paxalisib in Greater China to Simcere, a Leading Chinese Pharmaceutical Company - PR Newswire","headline":"Kazia Licenses Rights to Paxalisib in Greater China to Simcere, a Leading Chinese Pharmaceutical Company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTE0wQi03S094MDY4TTl5aklwREtZSGp3eEcxRTBiY3lnbm1UalFBVGtxVmJTMWFEQjdpZVkwV3k1VTEzYjAyNFRwQTRfM3B0UUlZWFE?oc=5","date":"2018-12-07","type":"pipeline","source":"sg.finance.yahoo.com","summary":"Kazia Therapeutics Limited (KZIA) stock price, news, quote and history - sg.finance.yahoo.com","headline":"Kazia Therapeutics Limited (KZIA) stock price, news, quote and history","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}